switched from semaglutide to tirzepatide and gained weight Early Dose Escalation of after Switching in Type 2 Diabetes Mellitus Rebound weight gain after stopping

CLAY We Are Not Your PCP

The goal is always long-term weight management, not quick fixes

Mitigating the Detrimental Effects of Type 2 Diabetes and Insulin Resistance: Chronic stress and inflammation contribute to insulin resistance

A tax credit is generally more tax-favored than a deduction

10.1038/s41467-024-52353-y Summary Keywords drug-drug interaction, ecnoglutide (XW003), GLP-1 receptor agonist, metformin, warfarin Citation Chen Z, Du C, Cai L, Feng S, Zou Q, Guo W, Li F, Du D, Hu F, Liu X, Huang Y, Shi S, Shi W, Yu Q, Zhang L, Guan L, Yang L, Li Y, Liu R, Ning J, Yang M and Zheng Q (2026) No dose adjustment required for warfarin or metformin when coadministered with the novel GLP-1 receptor agonist ecnoglutide: an open-label, fixed-sequence, crossover study

Nutritional Gaps: When you eat significantly less, you may need targeted support